Company / Operating Cash Flow per Share
Apyx Medical Corp Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.21
FY2025
5-year range
-$0.59 / -$0.21
FY2021-FY2025
Trend
+59.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has increased for 3 consecutive years, from $-0.59 in FY2022 to $-0.21 in FY2025.
Based on SEC 10-K filings.
-0.21 in FY2025.
Improved from $-0.59 to $-0.21 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Apyx Medical Corp's operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 59.4% year-over-year.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.21 | +59.4% |
| FY2024 | -$0.52 | +11.1% |
| FY2023 | -$0.59 | +0.5% |
| FY2022 | -$0.59 | -25.8% |
| FY2021 | -$0.47 | +13.3% |
| FY2020 | -$0.54 | -390.8% |
| FY2019 | -$0.11 | -27.7% |
| FY2018 | -$0.09 | +54.0% |
| FY2017 | -$0.19 | -1116.3% |
| FY2016 | -$0.02 | +89.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026